55091-3
Darunavir [Susceptibility] by Genotype method
Active
Part Descriptions
LP64724-5 Darunavir
Darunavir (Prezista) is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment-naïve and treatment-experienced adults and adolescents. Developed by pharmaceutical company Tibotec, darunavir is named after Arun K. Ghosh, the chemist who discovered the molecule at the University of Illinois in Chicago. It was approved by the Food and Drug Administration (FDA) on June 23, 2006.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Darunavir
LP64724-5 Darunavir
Darunavir (brand name Prezista, formerly known as TMC114) is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment-naïve and treatment-experienced adults and adolescents.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Fully-Specified Name
- Component
- Darunavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- Ord
- Method
- Genotyping
Additional Names
- Short Name
- Darunavir Islt Genotyp
- Display Name
- Darunavir Genotyping [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Darunavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.27
- Last Updated
- Version 2.73
- Change Reason
- Corrected Scale from OrdQn to Ord because Genotyping does not produce a quantitative susceptibility result
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 18184
Member of these Panels
LOINC | Long Common Name |
---|---|
49660-4 | HIV susceptibility panel by Genotype method |
Member of these Groups Get Info
LOINC Group | Group Name |
---|---|
LG41328-2 | DarunavirSusc| |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Darunavir: |
es-MX | Spanish (Mexico) | Darunavir: |
et-EE | Estonian (Estonia) | Darunaviir: Synonyms: Isolaat Järgarvuline Juhuslik Tundlikkus |
fr-CA | French (Canada) | Darunavir: |
fr-FR | French (France) | Darunavir: |
fr-BE | French (Belgium) | Darunavir: |
it-IT | Italian (Italy) | Darunavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità al genotipo virale |
nl-NL | Dutch (Netherlands) | darunavir: |
pt-BR | Portuguese (Brazil) | Darunavir: Synonyms: Prezista; |
ru-RU | Russian (Russian Federation) | Дарунавир: Synonyms: Вирусного генотипа чувствительность Порядковый Точка во времени; |
tr-TR | Turkish (Turkey) | Darunavir: |
zh-CN | Chinese (China) | 地瑞那韦: Synonyms: Darunavir; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=55091-3
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright